Lung Neoplasms  >>  epirubicin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00017186: Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

Completed
2
69
US
epirubicin hydrochloride, gemcitabine hydrochloride
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Malignant Mesothelioma
08/04
05/08
NCT00154739: Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC)

Completed
2
86
RoW
Gemcitabine, Cisplatin, Epirubicin
National Taiwan University Hospital
Non-Small Cell Lung Cancer
07/05
07/05

Download Options